Significance of C-reactive protein in predicting fetal inflammatory response syndrome

Pełen tekst

(1)P R A C E O R Y G I N A L N E poł ożn i ct wo. DOI: 10.17772/gp/57864. Ginekol Pol. 2015, 86, 926-931. Significance of C-reactive protein in predicting fetal inflammatory response syndrome Znaczenie białka C-reaktywnego w przewidywaniu zespołu płodowej reakcji zapalnej

(2)

(3) ! "# $ % &'

(4) ( ' )* +, 1. Vilnius University Clinic of Obstetrics and Gynecology, Vilnius, Lithuania ² Department of Neonatology, Vilnius University Hospital Santariškių Klinikos, Vilnius, Lithuania ³ Centre of Dermatovenereology, Vilnius University Hospital Santariškių Klinikos, Vilnius, Lithuania 4 Department of Immunology, State Research Institute Center for Innovative Medicine, Vilnius, Lithuania 5 Department of Chemistry and Bioengineering, Faculty of Fundamental Sciences, Vilnius Gediminas Technical University, Vilnius, Lithuania. Abstract Objectives: The aim of the study was to identify and evaluate a possible correlation between C-reactive protein (CRP) concentration in maternal blood and the risk of developing fetal inflammatory syndrome (FIRS). Material and methods: The study included 158 infants born at 22-34 weeks of gestation and their mothers. Umbilical cord blood cytokines were evaluated in immunoassay tests and maternal blood was tested for CRP concentration. Results: The period of gestation was significantly shorter in the FIRS group as compared to the control group (29.5±3.1 vs. 32.2±2.4 weeks, p<0.001). Gestational age was ≤30 weeks for 53.8% of the newborns in the FIRS group and 15.8% of the newborns in the control group (p<0.001). Maternal CRP before, during and after labor was significantly higher in the FIRS group as compared to the control group (p<0.001). Our study investigated the correlation between CRP in maternal blood and IL-6 concentration during the entire perinatal period (p<0.001). Conclusion: CRP concentration in the FIRS group was significantly higher than in controls before, during, and after labor. Thus, it seems safe to conclude that changing concentration of inflammatory factors in maternal blood are closely related to FIRS. Elevated CRP in maternal blood might signify a progressing intrauterine infection and herald the development of FIRS.. Key words: intrauterine infection / CRP / preterm delivery / IL-6 /. Corresponding author: Daiva Bartkevičienė Vilnius University Faculty of Medicine, Clinic of Obstetrics and Gynecology, Vilnius, Lithuania M.K.Čiurlionio street 21, LT-03101 Vilnius, Lithuania e-mail: daivabartk@gmail.com. 926. © Polskie Towarzystwo Ginekologiczne. Otrzymano: 03.03.2015 Zaakceptowano do druku: 01.04.2015. Nr 12/2015.

(5) Ginekol Pol. 2015, 86, 926-931. DOI: 10.17772/gp/57864. P R A C E. O R Y G I N A L N E po ł o ż n i c t wo. Daiva Bartkevičienė et al. Significance of C-reactive protein in predicting fetal inflammatory response syndrome.. Streszczenie Cel pracy: Określenie zależności między stężeniem białka CRP w surowicy krwi matki i ryzykiem wystąpienia zespołu odpowiedzi zapalnej płodu (fetal inflammatory response syndrome – FIRS). Materiał i metodyka: Badaniem objęto 158 noworodków urodzonych pomiędzy 22 a 34 tygodniem ciąży oraz ich matki. Oznaczano stężenie cytokinów w surowicy krwi pępowinowej za pomocą metody immunoenzymatycznej oraz stężenie CRP w surowicy krwi matki. Wyniki: Ciąża trwała statystycznie krócej w grupie FIRS w porównaniu z grupą kontrolną (29,5±3,1 vs 32,2±2,4 tyg., p<0,001). Ciąża trwała ≤30 tyg. w 53,8% przypadków w grupie FIRS oraz w 15,8% przypadków w grupie kontrolnej. Stężenie CRP w surowicy krwi matki przed, w czasie i po porodzie było statystycznie wyższe w grupie FIRS w porównaniu z grupą kontrolną (p<0,001). Badanie wykazało zależność między stężeniem CRP w surowicy krwi matki i stężeniem interleukiny – 6 podczas całego okresu perinatalnego (p<0,001). Wnioski: Stężenie CRP w grupie FIRS było statystycznie wyższe w porównaniu z grupą kontrolną przed, w czasie i po porodzie. Można wyciągnąć wniosek, że zmiany stężenia czynników zapalnych w surowicy krwi matki są związane z FIRS. Wyższe stężenie CRP w surowicy krwi matki może wskazywać na progresujące zakażenie wewnątrzmaciczne i możliwy rozwój FIRS.. Słowa kluczowe:

(6) / CRP /poród przedwczesny / interleukina-6 / Introduction. Material and methods. - ./0

(7) .

(8) 1 - .

(9)

(10) . 2. 11

(11) ,345 1 - . 678 9

(12) .. 1

(13) 13 8 - 1 :,3;<5 1 . . +<5 1 1

(14) 6=78 >. 1

(15) /?8+<50 2. 1 @

(16) . - . 1 @

(17) 1 1 6(A,78 1

(18)

(19)

(20) .

(21)

(22) . 1 19

(23)

(24) - .8 1

(25)

(26) 1 1

(27) B . 1 B /C$08 C$ .

(28) 1

(29) 1 B 2.

(30) . 9 -

(31) 34

(32)

(33) DE . -

(34)

(35) - B

(36) . . -

(37)

(38) 3 1 64 :78>.

(39) @

(40) 1 C$

(41) 1 2 1 . .-

(42) .

(43) -

(44) .

(45) 8# C$

(46) 1 - 64;A=78 1 3 . C$

(47)

(48)

(49) . 2 1..3 2 2 . . 1

(50) - 8 ' 1 .

(51)

(52)

(53)

(54) 1 B 2.

(55) . 2 2 1 . 1

(56) .

(57) 1 - .8

(58) . 2 1

(59) . 9

(60)

(61) 1F3

(62) /F0@ - . 2.

(63) . 1C$8. >.

(64) 3

(65) 2 1 ' F F

(66) H - 2 =<<:3=<<I8 %? (8,<< 2- /8 8- =51 2- . 0 - . 1

(67) 8%- <35 1 8 J

(68) ,; 1 - ==3(+ 2 1 . . 8 >. -

(69) 2 12K0 1L; M=0 1==3 (+2 4M(0

(70) .

(71) M+0-

(72) 1 -

(73) .

(74)

(75)

(76) /H-N;<8<< E 0

(77)

(78) . . 8>. ?

(79)

(80) 2 12K0 - .M=0

(81) . E

(82) M(01 1 M+0.

(83) 1 . 2- M,0-

(84)

(85) -H1N:8<<M40- . 1 . 2- M:0 1

(86) . 8 % 2- . . 2

(87)

(88) .

(89) . K 0 -

(90)

(91) -

(92) 34

(93) 1

(94) />OC3P0 2

(95) . 2- M =0 .

(96)

(97) 1 . -

(98)

(99) - 34 . 2- 2 C$ / 34 DE0

(100) / 34NE0M(0

(101) . . 2 1 F

(102)

(103) . - - 1 1 -M+0

(104) - 2 F

(105)

(106) -

(107)

(108) 1

(109) . -

(110)

(111) - 2 M ,0

(112) - 2 F

(113)

(114) - - 1 1 - . 1C$2 8 .

(115) 1

(116)

(117)

(118) .

(119) - .

(120)

(121) -

(122)

(123) 2- - 2 1 8

(124) 1

(125) -

(126) 2 1 . $

(127) . F 1 #

(128) 8 %1 - . . -

(129) -

(130) 2

(131) , 1 - 2

(132) - 8 Q . . . - 2

(133) 1 1+ 8 8,<< E 2 1* 3;<RF 8. Objectives >. 1 . 2 1 -

(134) - 2 F

(135)

(136) - . 1 C$ . 8. Nr 12/2015. © Polskie Towarzystwo Ginekologiczne. 927.

(137) P R A C E O R Y G I N A L N E poł ożn i ct wo. Ginekol Pol. 2015, 86, 926-931. DOI: 10.17772/gp/57864. Daiva Bartkevičienė et al. Significance of C-reactive protein in predicting fetal inflammatory response syndrome.. 34 >OC3P . -

(138)

(139) - 2 2 .

(140)

(141) - * 3 - /S $%0 / # $ % 0

(142)

(143) . 1

(144) T

(145) 8>. 1

(146) 1 S $% /) , #

(147) F

(148) U % $1 2 M> V$%02

(149)

(150) 8 $

(151) 2 1 . $$$

(152) 1 2 ,8<8 W$ ?8X - 1 2 2

(153) .

(154) $ t3 3

(155) # 3Q. 8 $ T 2 1 .

(156) - 2 . 8>. 3 1N<8<,2

(157)

(158) 9

(159) 8>.

(160) 9

(161) 1 2 - * .

(162)

(163) .

(164)

(165)

(166) /JF08

(167) .

(168) F 1 . /O8+08

(169) 1

(170) - 2 1 - . . $ $

(171)

(172) $ C 8. Results 7KHSDUWLFLSDQWV # . C$ .

(173) 2 =:8(W48, =;8(W,8=

(174) - . 11

(175) 2

(176) 9

(177) /L<8<,08>. - 1

(178) -- 1 -2 9

(179) .. . C$

(180) .

(181) /Y<8<(+ <8<<+

(182) 08 J

(183)

(184) - 2

(185)

(186) - 34

(187)

(188) - /Y<8<,0 >OC3P

(189)

(190) . -

(191)

(192) -- 1 -/Y<8<= <8<<:

(193) 0 6=78 >.

(194) 1

(195)

(196)

(197) . 2 . +=5 1 . . 8 >.

(198)

(199)

(200) 1

(201) . C$2 9

(202) 11 1 .

(203) /L<8<,08 H

(204)

(205) B

(206) . .

(207) +<8(5 1 .

(208) 8 >. 1 @

(209) 1 .

(210)

(211) . 2 . 1

(212) 11 - 2 . 2 /L<8<,08H

(213)

(214) . 2 .1 21 ,51

(215) . C$2. .

(216)

(217) .

(218) . 5 1 .

(219) /N<8<<08 O .

(220)

(221) . 2

(222) <5 1

(223) . C$8 >. ? 1 . 2- 2 - @ +I8+53- ,<8453/Y<8;=08# /(8(W=8I2 02

(224) 9

(225) /N<8<<0. . C$ /=I8,W(8 2 0 . .

(226) /(=8=W=8+2 08>. 2Z(<2 ,(8;5 1 . 2- . C$ ,8;5 1 .

(227) . Table I. Comparison of CRP concentration in maternal blood CRP concentration. . n = 52. Control group n = 106. p value†.

(228) mean±SD median [min – max]. 30.65±39.95 16.52 [0.50-212.00]. 10.91±33.77 3.38 [0.00-307.00]. <0.001.

(229)

(230) mean±SD median [min – max]. 37.54±39.54 29.53 [0.50–212.00]. 7.83±11.05 3.38 [0.00–65.19]. <0.001.

(231) mean±SD median [min – max]. 42.15±44.19 29.53 [0.66–212.00]. 12.86±18.22 4.14 [0.00-95.56]. <0.001. CRP: C-reactive protein; FIRS: fetal inflammatory response syndrome; †Mann–Whitney test; SD, standard deviation. Significant values are set in bold.. / N <8<<08 # 2 . 2 8+=+8:W,4+8< =<<48(,W,,+8 . C$

(232)

(233) /N<8<<08# -

(234)

(235) -H . 2- 2 :8(W<8 11

(236) - 2 . 2 - /L<8<,08

(237)

(238) - 2 1 (I 2- 8 -

(239) 2 1 2- 1 . C$ /Listeria monocytogenes0 1 .

(240) /Klebsiella pneumonia0/Y8<08 &53FRQFHQWUDWLRQLQPDWHUQDOEORRG 2

(241) F

(242)

(243) -- 1 1 -/>- 08 Q. ? - 11 1F- 1 /(<84,W(I8I,E0 /(:8,+W(I8,+ E0 1 /+=8,W++8I E0 - 2

(244) . C$ />- 08 > F

(245)

(246) 1 . C$ 2 9

(247) .. . .

(248) /N<8<<08 >.

(249)

(250) 1 F

(251)

(252) - 1

(253) . 1 C$ >- C = (8 7KHFRQFHQWUDWLRQRIF\WRNLQHVLQWKHXPELOLFDOFRUGEORRG S

(254) . 2- 2 1-

(255)

(256) - 34 >OC3P

(257) 8J

(258)

(259) - 2 F

(260)

(261) - 34

(262)

(263) . -

(264)

(265) - 1 1 -/N<8<<0/>- (08 O 9

(266) 11

(267) 2

(268) - 2 F

(269)

(270) - >OC3P

(271)

(272) . -

(273)

(274) - - 1 1 - /Y<8( <8 <8

(275) 0/>- 08. Table II. Critical values of CRP in maternal blood for predicting the development of fetal inflammatory response syndrome Critical value. AUC.

(276) . Sensitivity %. %. NPV %. PPV %. 6.37. 0.7183. 0.6171-0.8200. 66.7. 67.4. 81.1. 49.1. during labor. 6.79. 0.7678. 0.6643-0.8673. 71.4. 70.8. 84.0. 53.6. after labor. 10.18. 0.7338. 0.6340-0.8309. 64.3. 64.0. 79.2. 45.8. CRP concentration before labor. CI: confidence Interval; AUC: area under the ROC curve; PPV: positive predictive value; NPV: negative predictive value.. 928. © Polskie Towarzystwo Ginekologiczne. Nr 12/2015.

(277) Ginekol Pol. 2015, 86, 926-931. DOI: 10.17772/gp/57864. P R A C E. O R Y G I N A L N E po ł o ż n i c t wo. Daiva Bartkevičienė et al. Significance of C-reactive protein in predicting fetal inflammatory response syndrome.. Table III. Correlation between CRP concentration in maternal blood and cytokine concentration in the umbilical cord blood. &53FRQFHQWUDWLRQ before labor during labor after labor. r (p-value ) !. "#$. 0.4 (<0.001) 0.4 (<0.001) 0.4 (<0.001). 0.1 (0.3) 0.2 (0.1) 0.2 (0.1). Significant values are set in bold. Discussion C B 1

(278)

(279) [ T1 - 1

(280) 2.

(281) . 2 B 8C$1 -

(282)

(283)

(284) 2 . - .8 -

(285)

(286) 1 6(78 C$

(287) .

(288) * -

(289) 1

(290) /

(291) 340 . -

(292)

(293) --.

(294) ? 1C$31 / 9 1 B

(295) -

(296)

(297) 08 C$

(298) 1 1

(299) 8 34

(300) 1 - .

(301) 9

(302) 3

(303) 9

(304) 8Q.

(305) - .

(306) / 3>OC3P0

(307) . * -

(308) .

(309) .

(310) 9--

(311) > .

(312) 6+78 >. 3 34 F

(313) .

(314) 1 -

(315)

(316) - -

(317) 8 > . 2 . >OC3P . S= .

(318)

(319) /[- 1 2 T0

(320) .

(321)

(322) .

(323) 1 8 >. 1 1 - .

(324) ? 8 34 .

(325) 1

(326) .

(327) /F0 . 8>. 3 34 F

(328) . B . - . 6,A;78 F

(329) 11 . 1

(330) 1

(331) 8 O . .

(332) 1 12

(333) 9

(334) 6478 8

(335)

(336)

(337)

(338) .

(339) B 1 2 2. . - 2 .

(340) - .

(341)

(342) 6I78>. . 1 .

(343)

(344) 1 34 3 1 >OC 3; 2 1 - . . 2 .

(345) 1

(346)

(347) . 6=<A==78 %

(348)

(349) 1 . B

(350) -2

(351) 1 1 . 1 -

(352)

(353)

(354)

(355)

(356)

(357) 1 - 2 6=(A=:78 2 1 .

(358) 34 3

(359)

(360) -

(361) 2 . .

(362)

(363) 1 1

(364) - .8C .

(365) . -&

(366)

(367)

(368) 8 >. 1 1 1

(369) -

(370)

(371)

(372) -

(373) 6=;78 F . * . 8 1 . .

(374) 2 1F2.

(375) 1

(376) B

(377)

(378) =<3=, 8H

(379) - . . Nr 12/2015. Figure 1. ROC curve analysis for determining the clinical values of CRP in maternal blood before labor.. Figure 2. ROC curve analysis for determining the clinical values of CRP in maternal blood during labor.. Figure 3. ROC curve analysis for determining the clinical values of CRP in maternal blood after labor.. © Polskie Towarzystwo Ginekologiczne. 929.

(380) P R A C E O R Y G I N A L N E poł ożn i ct wo. DOI: 10.17772/gp/57864. Ginekol Pol. 2015, 86, 926-931. Daiva Bartkevičienė et al. Significance of C-reactive protein in predicting fetal inflammatory response syndrome.. 1

(381) . /

(382) 1

(383)

(384) . - .

(385) 1 B

(386) 88 3406=I78

(387) F

(388) - -

(389) 1 B 8 F

(390) . - 1

(391) 8 Q 8 -. . .

(392)

(393)

(394) 1 F . - . 1 ; 2 2 .

(395)

(396)

(397) 8 . F

(398)

(399) 2 8,E .. .

(400) 3 2 8% . .1

(401) .

(402) .

(403) 8F

(404)

(405)

(406) . -6=I78 2 1

(407) .

(408) - 2 C$ F - . 8Q 1 . F

(409)

(410) - - - . 8 . C$F2 9

(411) .. - 1 1 -

(412) .

(413) /N<8<<08% 2 9

(414) /N<8<<0 - 2 F

(415)

(416) - 34

(417)

(418) . -

(419)

(420) . 8

(421) - 1 - -

(422) - 2 F

(423)

(424) . C$ . -

(425) 6=;(<78 $ \ 8 F

(426)

(427)

(428)

(429) 2. 1 1 8% -

(430) . 2 2 . - . 1 . 1 - . 23 ..3 2.

(431) .2 - 1 . 1 /

(432) . - 1 08 %

(433)

(434) . . F

(435)

(436) 1N;E.

(437) 1 8 .2 . 2F

(438)

(439)

(440) -

(441)

(442) .

(443) . 2- 1

(444) / 88 -

(445) 06(78>. 11

(446)

(447) . 1F

(448) - 1 ? 6(=78. Conclusion F

(449)

(450) . C$ 2 9

(451) .. . .

(452) - 1 1 -8 >. .

(453) .

(454) . - B

(455) C$ F

(456)

(457) -.2 . . 1

(458) -C$ 8. 6. Mindaugas Šilkūnas – concept, analysis and interpretation of data, article draft. 7. Rasa A. Vankevičiūtė – analysis and interpretation of data, article draft. 8. Brigita Vaigauskaitė – analysis and interpretation of data, article draft. 9. Gražina Drąsutienė – concept, assumptions, study design, revised article critically. 10. Irena Dumalakienė – study design, acquisition of data, analysis and interpretation of data, article draft, revised article critically. Authors’ statement ³ >RS] S] ^Y MO\^SPc ^RK^ ^RO Z_LVSMK^SYX aSVV XY^ `SYVKÔ ^RO MYZc\SQR^] YP K. third party, as understood according to the Act in the matter of copyright and related rights of 14 February 1994, Official Journal 2006, No. 90, Clause 63, with respect to the text, data, tables and illustrations (graphs, figures, photographs); ³ ^RO\O S] XY mMYX»SM^ YP SXÔ\O]^]p aRSMR YMM_\] aROX ^RO K_^RY\ \OWKSX] SX. a financial or personal relationship which unjustly affects his/her actions associated with the publication of the manuscript; ³ KXc ZY]]SLVO \OVK^SYX]RSZ] YP ^RO K_^RY\] aS^R ^RO ZK\^cZK\^SO]. interested in the publication of the manuscript are revealed in the text of the article; ³ ^RO WKX_]M\SZ^ RK] XY^ LOOX Z_LVS]RON SX Y\ ]_LWS^ÔN ^Y KXc Y^RO\. journal. ³ =Y_\MO YP ºXKXMSXQ$ SWW_XYVYQSMKV ]^_NSO] YP MY\N LVYYN ]KWZVO] aO\O. funded by the Lithuanian State Science and Studies Foundation.. References 1. Pilypienė I, Drazdienė N, Dumalakienė I, [et al.]. Preterm Delivery and Fetal Inflammatory Response Syndrome. Med Teor Ir Prakt. 2008, 14 (1), 8–17. 2. Bartkeviciene D, Pilypiene I, Drasutiene G, [et al.]. Leukocytosis as a prognostic marker in the development of fetal inflammatory response syndrome. Libyan J Med. 2013, 8, 21674. 3. Romero R, Chaiworapongsa T, Kuivaniemi H, Tromp G. Bacterial vaginosis, the inflammatory response and the risk of preterm birth: a role for genetic epidemiology in the prevention of preterm birth. Am J Obstet Gynecol. 2004, 190 (6), 1509–1519. 4. Guinn D, Gibbs R. Infection-related Preterm Birth A Review of the Evidence. NeoReviews. 2002, 3 (5), e86–96. 5. Romero R, Chaiworapongsa T, Espinoza J. Micronutrients and intrauterine infection, preterm birth and the fetal inflammatory response syndrome. J Nutr. 2003, 133 (5 Suppl 2), 1668S-1673S. 6. Hofer N, Kothari R, Morris N, [et al.]. The fetal inflammatory response syndrome is a risk factor for morbidity in preterm neonates. Am J Obstet Gynecol. 2013, 209 (6), 542.e1–542.e11. 7. Pacora P, Chaiworapongsa T, Maymon E, [et al.]. Funisitis and chorionic vasculitis: the histological counterpart of the fetal inflammatory response syndrome. J Matern-Fetal Neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet. 2002, 11 (1), 18–25. 8. Bale JF, Murph JR. Congenital infections and the nervous system. Pediatr Clin North Am. 1992, 39 (4), 669–690. 9. Yoon BH, Romero R, Kim KS, [et al.]. A systemic fetal inflammatory response and the development of bronchopulmonary dysplasia. Am J Obstet Gynecol. 1999, 181 (4), 773–779. 10. Yoon BH, Romero R, Park JS, [et al.]. Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years. Am J Obstet Gynecol. 2000, 182 (3), 675–681. 11. Goldenberg RL, Thompson C. The infectious origins of stillbirth. Am J Obstet Gynecol. 2003, 189 (3), 861–873. 12. Gibbs RS. The origins of stillbirth: infectious diseases. Semin Perinatol. 2002, 26 (1), 75–78.. Authors’ contribution: 1. Daiva Bartkevičienė – concept, assumptions, study design, acquisition of data, article draft, revised article critically, corresponding author. 2. Ingrida Pilypienė – concept, assumptions, study design, acquisition of data, article draft, revised article critically. 3. Diana Ramašauskaitė – concept, assumptions, study design, acquisition of data, article draft, revised article critically. 4. Jolita Zakarevičienė – acquisition of data, article draft. 5. Dalia Laužikienė – concept, assumptions, study design, revised article critically.. 930. 13. Mittendorf R, Montag AG, MacMillan W, [et al.]. Components of the systemic fetal inflammatory response syndrome as predictors of impaired neurologic outcomes in children. Am J Obstet Gynecol. 2003, 188 (6), 1438–1434; discussion 1444–1446. 14. Keelan JA, Blumenstein M, Helliwell RJA, [et al.]. Cytokines, prostaglandins and parturition--a review. Placenta. 2003, 24 Suppl A, S33–46. 15. Bartkevičienė D, Dumalakienė I, Šilkūnas M, [et al.]. Bacterial vaginosis: risk factors and vaginal lavage cytokines IL-1b, IL-1ra. Sveik Moksl. 2011, 21 (6), 10–15. 16. Peltier MR. Immunology of term and preterm labor. Reprod Biol Endocrinol RBE. 2003, 1, 122. 17. Makhseed M, Raghupathy R, El-Shazly S, [et al.]. Pro-inflammatory maternal cytokine profile in preterm delivery. Am J Reprod Immunol N Y N 1989. 2003, 49 (5), 308–318.. © Polskie Towarzystwo Ginekologiczne. Nr 12/2015.

(459) Ginekol Pol. 2015, 86, 926-931. DOI: 10.17772/gp/57864. P R A C E. O R Y G I N A L N E po ł o ż n i c t wo. Daiva Bartkevičienė et al. Significance of C-reactive protein in predicting fetal inflammatory response syndrome.. 18. Gibb W, Challis JRG. Mechanisms of term and preterm birth. J Obstet Gynaecol Can JOGC. 2002, 24 (11), 874–883. 19. Ohlsson A, Wang E. An analysis of antenatal tests to detect infection in preterm premature rupture of the membranes. Am J Obstet Gynecol. 1990, 162 (3), 809–818. 20. Alvarez-de-la-Rosa M, Rebollo FJ, Codoceo R, Gonzalez Gonzalez A. Maternal serum interleukin 1, 2, 6, 8 and interleukin-2 receptor levels in preterm labor and delivery. Eur J Obstet Gynecol Reprod Biol. 2000, 88 (1), 57–60. 21. Yoon BH, Romero R, Kim CJ, [et al.]. Amniotic fluid interleukin-6: a sensitive test for antenatal diagnosis of acute inflammatory lesions of preterm placenta and prediction of perinatal morbidity. Am J Obstet Gynecol. 1995, 172 (3), 960–970. 22. Shimoya K, Matsuzaki N, Taniguchi T, [et al.]. Interleukin-8 level in maternal serum as a marker for screening of histological chorioamnionitis at term. Int J Gynaecol Obstet Off Organ Int Fed Gynaecol Obstet. 1997, 57 (2), 153–159. 23. Büscher U, Chen FC, Pitzen A, [et al.]. Il-1 beta, Il-6, Il-8 and G-CSF in the diagnosis of earlyonset neonatal infections. J Perinat Med. 2000, 28 (5), 383–388. 24. Hatzidaki E, Gourgiotis D, Manoura A, [et al.]. Interleukin-6 in preterm premature rupture of membranes as an indicator of neonatal outcome. Acta Obstet Gynecol Scand. 2005, 84 (7), 632–638. 25. Lockwood CJ, Murk WK, Kayisli UA, [et al.]. Regulation of interleukin-6 expression in human decidual cells and its potential role in chorioamnionitis. Am J Pathol. 2010, 177 (4), 1755–1764. 26. Bahar AM, Ghalib HW, Moosa RA, [et al.]. Maternal serum interleukin-6, interleukin-8, tumor necrosis factor-alpha and interferon-gamma in preterm labor. Acta Obstet Gynecol Scand. 2003, 82 (6), 543–549. 27. Greig PC, Murtha AP, Jimmerson CJ, [et al.]. Maternal serum interleukin-6 during pregnancy and during term and preterm labor. Obstet Gynecol. 1997, 90 (3), 465–469. 28. Skrablin S, Lovric H, Banovic V, [et al.]. Maternal plasma interleukin-6, interleukin-1beta and C-reactive protein as indicators of tocolysis failure and neonatal outcome after preterm delivery. J Matern-Fetal Neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet. 2007, 20 (4), 335–341. 29. Watts DH, Krohn MA, Wener MH, Eschenbach DA. C-reactive protein in normal pregnancy. Obstet Gynecol. 1991, 77 (2), 176–180. 30. Van der Heyden JL, van Teeffelen SSP, Coolen ACG, [et al.]. Is it useful to measure C-reactive protein and leukocytes in patients with prelabor rupture of membranes? Am J Perinatol. 2010, 27 (7), 543–547. 31. Lee SY, Park KH, Jeong EH, [et al.]. Relationship between Maternal Serum C-Reactive Protein, Funisitis and Early-Onset Neonatal Sepsis. J Korean Med Sci. 2012, 27 (6), 674–680. 32. Keane M, Fallon R, Riordan A, Shaw B. Markedly raised levels of C-reactive protein are associated with culture proven sepsis or necrotising enterocolitis in extremely preterm neonates. Acta Paediatr Oslo Nor 1992. 2015 Feb 19.. Nr 12/2015. © Polskie Towarzystwo Ginekologiczne. 931.

(460)